Home
PB Ratio of Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd
NSE: KREBSBIO
PB Ratio
Key Highlights
- The latest PB Ratio of Krebs Biochemicals & Industries Ltd is 0.
- The PB ratio of the Krebs Biochemicals & Industries Ltd is below 1 which indicates that the stock is undervalued.
- The P/B Ratio of Krebs Biochemicals & Industries Ltd changed from -5.9 on March 2020 to -1.1 on March 2024 . This represents a CAGR of -28.53% over 5 years.
Historical P/B Ratio of Krebs Biochemicals & Industries Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Krebs Biochemicals & Industries Ltd
Company Fundamentals for Krebs Biochemicals & Industries Ltd
Market Cap
170 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
0.0
Day’s High
82.81
Day’s Low
74.01
DTE
-1.6
ROE
16.7
52 Week High
129.0
52 Week Low
60.3
ROCE
-13.6
Market Price of Krebs Biochemicals & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
22 Apr 2025 | 79.21 |
21 Apr 2025 | 80.74 |
17 Apr 2025 | 77.54 |
16 Apr 2025 | 80.47 |
15 Apr 2025 | 76.5 |
11 Apr 2025 | 73.78 |
09 Apr 2025 | 71.29 |
08 Apr 2025 | 72.4 |
07 Apr 2025 | 71.19 |
04 Apr 2025 | 72.14 |
SWOT Analysis Of Krebs Biochemicals & Industries Ltd
BlinkX Score for Krebs Biochemicals & Industries Ltd
Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
Company | PB | Market Cap |
---|
Krebs Biochemicals & Industries Ltd | - | 170.78 |
Sun Pharmaceutical Industries Ltd | 98.3 | 419224 |
Divis Laboratories Ltd | 513.6 | 157046 |
Cipla Ltd | 360.7 | 123412 |
Torrent Pharmaceuticals Ltd | 222.4 | 109829 |
PB Ratio of Krebs Biochemicals & Industries Ltd Explained
₹170.78
Market cap
₹-60
Book Value per Share
0.0X
PB Ratio
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.
How to calculate Price-to-Book (P/B) Ratio?
The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.
Market capitalization = market value of a stock X no. of outstanding shares
Now, you need to know the net value of an organization's assets.
Book Value of Assets = Total Assets - Total Liabilities of a company
After knowing the value of the above ratios, here is the formula for the P/B Ratio:
P/B Ratio = Market Capitalization/ Book Value of Assets
or you can also use this formula
P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical Market Cap of Krebs Biochemicals & Industries Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Krebs Biochemicals & Industries Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Krebs Biochemicals & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Krebs Biochemicals & Industries Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Krebs Biochemicals & Industries Ltd News Hub
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024
Read more
07 Aug 24
Krebs Biochemicals & Industries schedules AGM
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company
Read more
09 Sept 24
Krebs Biochemicals & Industries to conduct board meeting
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N
Read more
29 Oct 24
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September
Read more
11 Nov 24